Veeva Systems Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Peter Gassner
- Full Time Employees
- 7,291
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 4280 Hacienda Drive Pleasanton CA United States of America 94588
- IPO Date
- Oct 16, 2013
- CIK
- 0001393052
- Website
- veeva.com
- Similar Companies
- Business
- Veeva Systems Inc. (NYSE: VEEV) provides cloud-based software solutions, data, and services for the global life sciences industry, spanning research and development through commercialization; its core offerings include the Veeva Vault Platform with applications for clinical operations such as Vault EDC and Vault CDMS, regulatory management, quality processes via Veeva QualityOne, safety and pharmacovigilance, medical affairs, and commercial functions through Veeva CRM and the transitioning Vault CRM suite; additional solutions cover customer master data management, content management, and AI-enhanced tools like Veeva AI Agents. Veeva operates as a public benefit corporation headquartered in Pleasanton, California, with offices across North America, Europe, Asia, and Latin America, serving over 1,000 customers from large biopharmaceutical firms to emerging biotechs. Founded in 2007, the company targets regulated industries including pharmaceuticals, biotechnology, MedTech, and expansions into consumer goods, cosmetics, and chemicals. Recent developments include the October 2024 strategic partnership with Walgreens to enrich Veeva Data Cloud and enhance patient outcomes through integrated access to Veeva Clinical Platform; an expanded collaboration with Roche announced November 24, 2025; a partnership with Amgen in August 2025 to advance clinical trial innovation; the launch of Vault CRM in 2024 as a next-generation CRM migrating from Salesforce to Veeva's Vault platform, with new modules like Vault CRM Service Center and forthcoming Vault CRM Bot using generative AI; and the December 2025 availability of Veeva AI Agents to boost productivity.
Veeva Expands Safety Suite Footprint With UCB Pharmacovigilance Deal
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Reasons to Add Veeva Systems Stock to Your Portfolio for Now
Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term
UCB vereinheitlicht seine weltweiten Pharmakovigilanz-Aktivitäten mit der Veeva Safety Suite
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
Here's Why Veeva Systems (VEEV) is a Strong Momentum Stock
UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
Wall Street Analysts Predict a 41.87% Upside in Veeva (VEEV): Here's What You Should Know
Is It Worth Investing in Veeva (VEEV) Based on Wall Street's Bullish Views?
Veeva Systems Q1 Earnings Call Highlights AI Push & Higher Outlook
Veeva Rides AI Wave As Pharma Cloud Story Accelerates
VEEV Stock Down Despite Q1 Earnings & Revenues Beat Estimates
Dow Soars Over 800 Points to Record High as Tech Wanes
Breakfast News: CRWD Fails To Clear Elevated Bar
Veeva Summit Previews Falcon and the Path to Agentic Biopharma
Veeva Systems Inc (VEEV) Q1 2027 Earnings Call Highlights: Surpassing Revenue Guidance and Unveiling AI Innovations
Veeva Systems Inc. (VEEV) Q1 2027 Earnings Call Transcript
Here's What Key Metrics Tell Us About Veeva (VEEV) Q1 Earnings